However, inhibiting autophagy by 3-MA counteracted the effects of P-gp siRNA treatment on ischemic stroke outcome as indicated by enlarged infraction size, increased brain edema, worsened neurological defects and brain histopathology (Fig. 4B-4E, P<0.05, P<0.01). The gene discussed is PGP; the disease is ischemic stroke.